For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first ...
Since 2021, Korean researchers have been providing a simple software development framework to users with relatively limited AI expertise in industrial fields such as factories, medical, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback